Toggle navigation
Home
Search
Services
Blog
Contact
About
Controlled Gene Therapy Using a Molecular Switch
Eastman, Eric M.
Valentis, Inc., Burlingame, CA, United States
Search grants from Eric Eastman
Search grants from Valentis, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Massachusetts Institute of Technology
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
The genomic basis of environmental adaptation in mice
Ectopic fat and atherosclerosis in South Asians
Mapping HIV/AIDS genes with haplotype-based strategies
Phenylacetate in Pediatric Patients W/ Central Nervous System Tumors
Investigations of DNA Photolyase Enzymes
Recently added grants:
Dynamics of Influenza Transmission in Nicaraguan Households
Novel Mechanisms of Beta-lactam Resistance in Staph Aureus
Physiological roles of schistosome TRP ion channels with atypical pharmacology
The role of VTA neurotransmitter co-release in health and disease
IRF4+ respiratory dendritic cells in type 2 inflammatory responses
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Small Business Innovation Research Grants (SBIR) - Phase II (R44)
Project #
2R44NS033069-02
Application #
2037813
Study Section
Special Emphasis Panel (ZRG7-SSS-2 (22))
Project Start
1994-06-10
Project End
1998-08-31
Budget Start
1996-09-30
Budget End
1997-08-31
Support Year
2
Fiscal Year
1996
Total Cost
Indirect Cost
Institution
Name
Valentis, Inc.
Department
Type
DUNS #
City
Burlingame
State
CA
Country
United States
Zip Code
94010
Related projects
NIH 1997
R44 NS
Controlled Gene Therapy Using a Molecular Switch
Nordstrom, Jeffrey L. / Valentis, Inc.
NIH 1996
R44 NS
Controlled Gene Therapy Using a Molecular Switch
Eastman, Eric M. / Valentis, Inc.
Comments
Be the first to comment on Eric Eastman's grant